Pfizer's (PFE) planned $68B purchase of Wyeth (WYE) prompts the inevitable who's next?...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer's (PFE) planned $68B purchase of Wyeth (WYE) prompts the inevitable who's next? Bristol-Myers (BMY) is "most likely candidate for the next acquisition," Natixis Bleichroeder says, and could fetch $38/share. BMY +1.8% to $22.80.